Clinical Research Pharmacists are specialized healthcare professionals who bridge the gap between pharmaceutical science and clinical research. They play a crucial role in the planning and execution of clinical trials involving investigational drugs. Their responsibilities include evaluating drug protocols for appropriate dosing, potential interactions, and monitoring safety parameters. By collaborating closely with clinical investigators, research coordinators, and regulatory bodies, these pharmacists ensure that trial designs are scientifically sound and patient safety is prioritized. Their deep understanding of pharmacokinetics and pharmacodynamics supports accurate interpretation of clinical data, which is essential for determining a drug’s efficacy and safety profile.
In addition to protocol assessment, Clinical Research Pharmacists oversee the handling, storage, and dispensing of investigational medications according to strict regulatory and Good Clinical Practice (GCP) standards. They maintain precise drug accountability records and ensure compliance with all documentation requirements. Furthermore, they provide education and guidance to healthcare teams and patients regarding investigational drugs, side effect management, and adherence to study procedures. Their dual expertise in pharmacy and clinical research makes them indispensable for maintaining the quality and integrity of clinical trials, ultimately facilitating the development of new, safe, and effective therapeutic options for patients worldwide. As clinical research continues to evolve, their role remains critical in advancing innovative treatments.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada